Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 12, 2008
[Toll-like receptor in lung response to pathogens]Bruno Rivas-Santiago, Esmeralda JuárezCurrent Pharmaceutical Design|March 29, 2018
Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes?Bruno Rivas-Santiago, Flor Torres-JuarezScandinavian Journal of Infectious Diseases|January 24, 2014
Novel approaches to tuberculosis prevention: DNA vaccinesBruno Rivas-Santiago, Alberto R Cervantes-VillagranaInvestigacion Clinica|December 16, 2005
[Cell immunity response in human pulmonary tuberculosis. Review]Bruno Rivas-Santiago, Patricia Vieyra-Reyes, Zaida AraujoArchivum Immunologiae Et Therapiae Experimentalis|September 16, 2021
Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?Bruno Rivas-Santiago, Yolanda Jacobo-Delgado, Adrian Rodriguez-CarlosInfection and Immunity|August 26, 2009
Susceptibility to infectious diseases based on antimicrobial peptide productionBruno Rivas-Santiago, Carmen J Serrano, J Antonio Enciso-MorenoSalud Publica De Mexico|March 25, 2006
[Antimicrobial peptides in the innate immunity of infectious diseases]Bruno Rivas-Santiago, Eduardo Sada, Rogelio Hernández-Pando, et al.Immunotherapy|October 4, 2013
Immunotherapy for pulmonary TB: antimicrobial peptides and their inducersCesar Enrique Rivas-Santiago, Rogelio Hernández-Pando, Bruno Rivas-SantiagoRevista Medica Del Instituto Mexicano Del Seguro Social|September 28, 2023
[Potential use of liposomes in tuberculosis treatment]Yolanda Monserrath Jacobo-Delgado, Gabriela Navarro-Tovar, Bruno Rivas-SantiagoCytokine|June 11, 2026
Progranulin as a context-dependent regulator of innate immunity in bacterial infectionsCamelia Félix-Arellano, Cesar Rivas-Santiago, Eva Salinas, et al.Pageof 11